Pharmaceutical - Revolade

Filter

Current filters:

Revolade

Popular Filters

New Zealand funding plans for Tarceva and Revolade

New Zealand funding plans for Tarceva and Revolade

09-12-2013

Following a consultation, New Zealand’s Pharmaceutical Management Agency PHARMAC said this morning…

Asia-PacificGlaxoSmithKlineHematologyNew ZealandOncologyPharmaceuticalPricingRegulationRevoladeRocheTarceva

GSK's Revolade recommended by UK's NICE for low blood platelet counts

24-07-2013

The UK's drugs watch dog the National Institute for Health and Care Excellence (NICE) has recommended…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRevolade

Positive NICE news for GSK's Revolade and InterMune's Esbriet

21-03-2013

UK drugs watchdog the National Institute for Health and Clinical Excellence today (March 21) issued two…

BiotechnologyEsbrietEuropeGlaxoSmithKlineImmunologicalsInterMunePharmaceuticalPricingRegulationRespiratory and PulmonaryRevolade

Back to top